Next Article in Journal
Extracellular Acetylated Histone 3.3 Induces Inflammation and Lung Tissue Damage
Next Article in Special Issue
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Previous Article in Journal
ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis
Previous Article in Special Issue
Metformin Prevents NDEA-Induced Memory Impairments Associated with Attenuating Beta-Amyloid, Tumor Necrosis Factor-Alpha, and Interleukin-6 Levels in the Hippocampus of Rats
 
 
Article
Peer-Review Record

Olfactory Dysfunction Is Associated with Cerebral Amyloid Deposition and Cognitive Function in the Trajectory of Alzheimer’s Disease

by Sheng-Min Wang 1, Dong Woo Kang 2, Yoo Hyun Um 3, Sunghwan Kim 1, Chang Uk Lee 2 and Hyun Kook Lim 1,*
Reviewer 2:
Submission received: 13 July 2023 / Revised: 17 August 2023 / Accepted: 28 August 2023 / Published: 31 August 2023
(This article belongs to the Special Issue Advances in Biomarkers for Neurodegenerative Diseases)

Round 1

Reviewer 1 Report


Comments for author File: Comments.pdf


Author Response

Author response)

 Thank you very much for your comprehensive review of our paper. We would also like to thank you for your encouraging comments. In order to make our paper more logical and valid, we made corrections based your comments. The responses to your comments are appended by point-to-point and all the changes are indicated in the revised version with yellow highlights.

Author Response File: Author Response.pdf

Reviewer 2 Report

This paper was well and scientifically written. However, I found a few points that need to be considered to make this paper better. 

1. In this paper, there were no differences in B-SIT scores between the A-PET (+) MCI and AD dementia groups. Therefore, the title "Olfactory Dysfunction is Associated with ....and Disease Severity in Alzheimer’s Disease" is incorrect and need to be modified. In conclusions, "Olfactory deficits appear to parallel the progression of AD pathology and may serve as an additional marker for disease progression" should also be corrected. 

2. Please show the B-SIT scores of A-PET (-) dementia and compare with other groups. 

3. Olfactory test may be impossible for moderate to sever dementia patients because of their cognitive impairments.  And in your study,  there were no differences in B-SIT scores between the A-PET (+) MCI and AD dementia groups. Therefore olfactory test may be useful in MCI stage. Please describe this limitation in the discussion. 

4.  Please show the results of the comparisons between groups in table 1. 

Spelling errors in lines 143, 197, and 218. 

Author Response

Author response)

 Thank you very much for your comprehensive review of our paper. We would also like to thank you for your encouraging comments. In order to make our paper more logical and valid, we made corrections based your comments. The responses to your comments are appended by point-to-point and all the changes are indicated in the revised version with yellow highlights.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

None

Back to TopTop